๐ฏ Objectives
To familiarize the students with the:
- Various NT and their role in the modulation of behaviors ๐ง
- Classification of Neurotransmitters ๐: Monoamines: Catecholamines ๐งช and Indoleamine ๐, acetylcholine ๐ฏ, amino acid ๐งฌ, and Peptide ๐
- Neurotransmitter's role in modulation of behaviors and Aberration โ ๏ธ
- Drugs and Behavior ๐๐ญ
- Classification of Psychopharmacological substances ๐ฌ
- Behavioral correlates, Treatment ๐ฉบ
- Mechanism of synaptic transmission ๐ก
๐ญ NE and Behaviors (continued)
๐ฐ Stress
There are various ways in which stress can be induced in the laboratory ๐ฌ. One of these methods is to give continuous and inescapable shocks โก. Rats are placed in a cage with a steel wire grid on the floor ๐. Shock is passed through these to the rat's feet ๐ฆถ (the paw and feet are the only part apart from their nose which does not have fur protection ๐งฅ).
Stress induced by foot shocks ๐ฐ (stress) lead to increased NA levels and turnover in the hindbrain โฌ๏ธ๐. The turnover rates increase means that more and more NA is being used and being metabolized ๐. This has been measured using the push pull cannulae ๐. Various pharmacological procedures have also shown that only NA increases after foot shock โ .
โก Electroconvulsive Therapy
Similarly, Electroconvulsive therapy ๐ฉบ also leads to increased NA levels in the forebrain ๐. Trauma of all kinds also increased NA activity in the brain โฌ๏ธ.
๐ฝ๏ธ NA and Feeding
Feeding is one of the basic motivations of animals ๐๐ด. The NA systems also are involved in the control of feeding behaviors ๐ง . If NA is administered directly in Lateral Hypothalamus ๐ leads to increased eating in animals which have already eaten to the point of satiation ๐ฝ๏ธโ (they are full and they stop eating in the normal state ๐). How do we know it is NA only? โ When we inject drugs which specifically for block NA ๐, the NA induced feeding is also blocked (no NA, no feeding!) ๐ซ๐ด.
๐ฌ Research Evidence
This is demonstrated by injections of Phentolamine ๐ (A-adrenergic blocker), which leads to a blockade of NA induced feeding ๐.
Liebowitz (1971) ๐ฉโ๐ฌ, a well-known researcher has shown through her experiments that NA may be acting to reduce the inhibition of the normal inhibition of lateral hypothalamic feeding center by the Ventromedial hypothalamus (VMH) ๐ฅ. So, the LH starts the feeding ๐ดโก and the VMH stops it ๐ (by telling LH to stop sending signals for eating). When NA is injected ๐, it stops the inhibition of VMH ๐ซ๐, so that messages of feeding can continue ๐ฝ๏ธโ.
๐ NE and Self-Stimulation: ICS
Positive Reinforcement or "reward" ๐ is linked with NA. Learning and conditioning using positive reinforcers or rewards are linked to intercranial self-stimulation or the self-stimulation โก. Positive ICS areas are areas in the brain where implanted electrodes would get maximal response of self-stimulation by the animals ๐. The animals would repeatedly press levers for electrical stimulation to these areas in the brain ๐โก. These areas closely correspond to distributions of NA and DA systems ๐งช, indicating that these neurotransmitters are modulating the reward behaviors ๐ญ.
๐งช Experimental Evidence
If we inject alpha methyl paratyrosine ๐, we reduce the amounts of tyrosine, DA and NA โฌ๏ธ. This injection also blocks the self-stimulation response in animals which were stimulating before the injection of AMPT ๐ซ.
โ Identifying the Specific NT
How do we know which one of these two neurotransmitters is involved? โ Logically following it we would use a drug which would block only DA ๐, or only NA ๐, or 5HT ๐ one by one after AMPT?
When we do so, we see that the AMPT blockade is reversed by the Alpha receptor agonists of NA โ , not by B-receptor agonists or DA agonists or 5HT agonists โ. Thus, showing that NA is involved โก.
๐ฌ Push-Pull Cannulae Research
Researchers have also used the Push pull cannuleas ๐ in Ventricle to pull out the metabolites after self-stimulation. It was reported that with the self-stimulation leads to an increase in the release of NA โฌ๏ธ. Further it has been shown that the NA Dorsal bundle is more than the Ventral bundle ๐.
๐ข NA and Depression
The effectiveness of Monoamine Oxidase Inhibitors ๐ in treatment of depression has provided support to the Catecholamine hypothesis of Depression ๐ง , and in particular the involvement of NA ๐ซ.
This involvement is indicated by the fact that long term anti depression treatment in animals leads to a reduction in NA stimulated cyclic AMP ๐ (Beta receptors involved). This indicates that more NE stays available โฌ๏ธ (as it is not degraded) therefore less needs to be released โฌ๏ธ.
๐ Antidepressant Effects
Antidepressant also increases the synaptic availability of NE (more NA becomes available) โฌ๏ธ.
โ ๏ธ Reserpine and Depression
Reserpine ๐ (which has been used for treating mental illness in the Indian subcontinent since ages) when injected into the brain leads to depression like syndrome ๐ข (remember, it destroys the storage vesicles ๐ฅ and depletes NE, DA and 5HT from the presynaptic membrane โฌ๏ธโฌ๏ธโฌ๏ธ).
โ Iproniazid Treatment
Iproniazid ๐ (which is an MAOI and an effective antidepressant) when administered increased brain concentrations of NE and 5HT โฌ๏ธ. Thus, showing that NA is involved in depression, as decreases in NA lead to depression ๐ข, and reward behaviors as depletion of NE reduced self-stimulation ๐โ.
๐ Major Neurotransmitters: Monoamines: Indolamines
๐ Serotonin: Indolamine
Serotonin (also known as 5-hydroxytryptamine or 5-HT) ๐ is one of the major neurotransmitters of the brain with an important role in several behaviors (ranging from sleep ๐ด to depression ๐ข). The neurons are known as serotonergic neurons ๐งฌ and the pathways as serotonergic pathways ๐ค๏ธ.
๐ Historical Discovery
Scientists had known since the mid-19th century ๐ that there is a substance involved in powerful contraction of the smooth muscles ๐ช. Later, this was also found in the Ohio research labs ๐บ๐ธ to be the possible cause of high blood pressure ๐ฉบ, in American labs, this was called serotonin around the same time Italian scientists ๐ฎ๐น were trying to identify the substance in the intestinal mucosa, and also of the gut which led to powerful contractions of smooth muscle of the intestinal tract ๐ซ. This substance was called Enteramine by the Italian scientists. This substance is also found in clotted blood ๐ฉธ. These two groups of scientists eventually found that this substance was identical to 5-hydroxytryptamine (5HT) ๐งช. This has a strong resemblance to Lysergic acid diethylamide (LSD) molecule ๐.
๐งฌ Synthesis and Distribution
In the brain 5HT is synthesized in the same way as NE and DA from the precursor which is taken from the circulating blood ๐ฉธ. The precursor for 5HT is Tryptophan ๐งฌ, which varies according to the daily intake of the Tryptophan rich foods ๐ฝ๏ธ (milk ๐ฅ, red meat ๐ฅฉ, fruits such as bananas ๐ pineapples ๐ etc.).
The body and the brain both have a high concentration of 5HT ๐, where it is synthesized independently ๐ญ. About 90% of 5HT is found in the gastrointestinal area (in the enterochromaffin cells of the intestine) ๐ซ and only about 1-2% in the brain ๐ง .
๐ The Pineal Gland
The highest concentration of 5HT in the brain is found in the pineal gland ๐. The Pineal gland is a very small organ lying on the dorsal surface of the thalamus ๐ง . The pineal contains all the enzymes for the use of serotonin in addition to two other enzymes for transformation of serotonin โ๏ธ. The pineal contains about 50% more serotonin per gram of the brain that the rest of the brain areas ๐. (Wonder why?) โ
๐ Melatonin
The extension of pineal serotonin is Melatonin ๐. In the pineal, Tryptophan is transformed into N-Acetyl Serotonin, which is then transformed into Melatonin ๐. Melatonin is the substance which you see when your skin gets darkened by the sun (more melatonin, more pigmentation) ๐๐จ.
Melatonin secretion is enhanced by light โ๏ธ and suppressed by darkness ๐. Thus, Melatonin content is affected by the Light Dark (L/D cycles) ๐ and this bring daily and seasonal changes in the 5HT content in the pineal and the brain ๐ .
We will talk more about serotonin's involvement in day night cycles (sleep) ๐ด๐, in the later part of this lesson ๐.
โ๏ธ Serotonin Synthesis
We will discuss the synthesis of serotonin and where it begins and the enzymatic actions which occur ๐งช. We must be again very clear that the brain synthesizes its own serotonin from the amino acid ๐ญ.
1๏ธโฃ Tryptophan
This is the first step in the synthesis pathway ๐ฌ. Tryptophan enters the cells but in competition with phenylalanine (daily variation depends upon the consumption of tryptophan rich foods ๐ฝ๏ธ).
2๏ธโฃ Hydroxylation of Tryptophan
This is the rate limiting step โ ๏ธ. The hydroxylation of tryptophan takes place immediately at the 5th position of the molecule to form 5-Hydroxytryptophan or 5HTP ๐งฌ. The enzyme involved in this action is Tryptophan hydroxylase โ๏ธ.
This step can be blocked by a drug called Parachlorophenylalanine (PCPA) ๐๐. PCPA competes with tryptophan for this enzyme and binds irreversibly with this enzyme ๐. In rats ๐ one injection of PCPA of 200 mg/kg depletes brain 5HT drastically (to about 20%) โฌ๏ธ and recovery to normal levels can take weeks โฐ.
3๏ธโฃ Decarboxylation
5HTP is immediately decarboxylated to form 5HT โก. The decarboxylating agent is the one similar to Dopa (the same protein is used in the Catecholamines and Serotonin neurons for decarboxylation) ๐งช. The enzyme L-Amino Acid Decarboxylase is involved in this action โ๏ธ.
4๏ธโฃ Deactivation
Serotonin is deactivated or deaminated by Monoamine Oxidase (MAO) ๐งช as in the other monoamines. The metabolite of this action is 5-Hydroxy Indole Acetic Acid (5-HIAA) ๐ฌ.
๐บ๏ธ Serotonergic Anatomical Location and Pathways
Though attempts had been made to identify the pathways of 5HT ๐, it became possible only after Falck and Hillarp's ๐จโ๐ฌ formaldehyde induced fluorescence histochemcial procedures became well known ๐, and through the immunocytochemcial methods (through retrograde transport) ๐ฌ, and procedures using radiolabelled amino acids taken up by the orthograde axoplasmic system when injected into the neurons ๐.
Dahlstrom and Fuxe (1964) ๐ and other researchers identified about nine clusters of 5HT neurons in the nuclei of the raphe system ๐ง located in the midline of the pons and upper brain stem. These are spread out like islands (or a bunch of grapes ๐).
โฌ๏ธ Ascending 5HT Bundles
Ascending 5HT bundles travel through the Medial Forebrain Bundle ๐ค๏ธ with terminals in:
- Reticular formation ๐ง (You will find out later why this connection is important โญ)
- Hypothalamus ๐ฅ
- Lateral geniculate nuclei ๐๏ธ
- Preoptic area ๐ง
- Hippocampus ๐
- Cortex ๐ง (crucial role in sleeping and awakening ๐ดโฐ)
These also project into the telencephalon and the diencephalon ๐ง , and descend into the spinal cord ๐ฆด (Cooper, Bloom and Roth, 7th edition) ๐.
๐ค๏ธ Pathways
There are several serotonergic pathways each with their own connection and receptors ๐. Nuclei Raphe comprise of several different groups. The Dorsalis, Superior and Magnus nuclei pass through the MFB ๐ง .
๐ต Nuclei Raphe Dorsalis
The serotonergic receptors here are B7 ๐ต. It sends projections to:
- Neocortex ๐ง
- Olfactory bulb ๐
- Thalamus ๐ฏ
- Amygdala ๐
- Hippocampus ๐
- Substantia Nigra ๐ค
- Locus Cerelleus ๐ง
๐ข Nuclei Centralis Superior
The serotonergic receptors are known as B8 ๐ข. They project to:
- Cerebral cortex ๐ง
- Hippocampus ๐
- Superchiasmatic nuclei (SCN) โ๏ธ
- Anterior hypothalamus ๐ฅ
- Medial preoptic area ๐ง
- Raphe dorsalis ๐ต
๐ด Nuclei Raphe Magnus
The serotonergic receptors here are B3 ๐ด. They extend to medulla and the anterior hypothalamic area ๐ง .
๐ฃ Nuclei Raphe Obscurus
This is an interesting pathway as the powerful hallucinogen LSD ๐ acts here. The receptors here are known as B2 ๐ฃ.
๐ก Raphe Pallidus
Has B1 receptors ๐ก, it contains substance P ๐ (a peptide) involved in Pain โ ๏ธ, goes down into spinal cord ๐ฆด.
๐ Steps in 5HT Synthesis Where Drugs Can Modulate Action
Step 1๏ธโฃ: Synthesis by Enzyme
Tryptophan is converted into 5 hydroxytryptophan by tryptophan hydroxylase in the serotonergic neuron โ๏ธ. This process can be blocked by the action of PCPA ๐ which uses up the hydroxylating enzyme ๐.
Step 2๏ธโฃ: Storage
Reserpine ๐, a major tranquilizing agent affects DA, NE and 5HT storage vesicles by irreversibly damaging the storage vesicles ๐ฅ. It is not clear whether DA, NE and 5HT responsible for behavioral depression ๐ค.
However, researchers have found that when Reserpine is administered along with 5HTP or DOPA ๐, there are increases in sedation (induced by reserpine) ๐ด. Injections of PCPA (removed 90% of the brain serotonin) โฌ๏ธ before reserpine, no behavioral effects of reserpine were seen ๐ซ.
Step 3๏ธโฃ: Release
There are no drugs which are specific serotonin blocking agents ๐ซ, but a major hallucinogenic drug Lysergic Acid Diethylamide (LSD) ๐ potentiates serotonin effects in low doses โก.
LSD inhibits the release of serotonin by blocking the firing of serotonergic neurons (indirect blocking) ๐.
LSD in high doses โฌ๏ธ- led to an increase in 5HT levels by reducing break down of serotonin (measured through reduced metabolites i.e., 5HIAA) ๐.
โฌ๏ธ Increased LSD Dosages
Increase LSD dosages reduced 5HT turnover rates, how? ๐ค
- Serotonin receptor sites occupied ๐
- Inhibit serotonin production by blocking action of 5HT ๐
- LSD appears to decrease the release of 5HT โฌ๏ธ
Step 4๏ธโฃ: Receptor Interaction
LSD acts as a partial agonist at the receptor sites of post-receptor membrane ๐ฏ.
Step 5๏ธโฃ: Reuptake
Serotonin action can be terminated by reuptake in the presynaptic area โป๏ธ. Tricyclics such as Imipramine ๐ also increase 5HT levels by inhibiting reuptake โฌ๏ธ. The Selective serotonin Reuptake inhibitors (SSRI's) ๐ are effective for treatment of anxiety ๐ฐโ .
Step 6๏ธโฃ: Degradation
Degradation by MAO can be inhibited by MAOI ๐. Iproniazid ๐ blocks MAO action in the presynaptic area ๐.
Thus, we have seen that in a manner to other neurotransmitters ๐งช, drugs interact with 5HT at various sites and can modulate levels of 5HT ๐, and these drugs are also effective in treating psychopathology ๐ฉบโ .
๐ References
- Kalat, J.W. (1998). Biological Psychology. Brooks/ Cole Publishing
- Carlson, N. R. (2005). Foundations of physiological psychology. Pearson Education New Zealand.
- Pinel, J. P. (2003). Biopsychology. (5th ed). Allyn & Bacon Singapore.
- Bloom, F., Nelson., & Lazerson. (2001), Behavioral Neuroscience: Brain, Mind and Behaviors. (3rd ed). Worth Publishers New York
- Bridgeman, B. (1988). The Biology of Behavior and Mind. John Wiley & Sons, New York
- Brown, T.S. & Wallace, P.S. (1980). Physiological Psychology. Academic Press, New York
- Seigel, G. J., Agranoff, B.W, Albers W.R. & Molinoff, P.B. (1989). Basic Neurochemistry: Molecular, Cellular and Medical Aspects
- Cooper, J.R., F.E Bloom, F. E., & Roth, R. H. (1970). The Biochemical basis of neuropharmacology (5th Ed.). New York, Oxford Univ. Press.